THTX שווי כולל של נכסי החברה Theratechnologies, Inc.
Theratechnologies Inc. (THTX) focuses on developing oncology and immunology treatments for the global market, mitigating risks through a broad development pipeline. The stock's price history confirms this trajectory, with total assets amounting to 60.74. Physicians value Theratechnologies Inc. (THTX) for its therapies targeting rare metabolic disorders and HIV. The technological foundation relies on packaging automation and the implementation of digital logistics control.
פילוחים אנליטיים ודוחות נתונים של חברת Theratechnologies Inc (THTX)
Total assets represent the aggregate value of the company's resources, calculated inversely via return on assets (ROA). For Theratechnologies Inc. (THTX), this metric reflects the capitalization of capacities for peptide drug production and the development of therapies for endocrine disorders. By analyzing fluctuations in total assets, an investor can identify the impact of credit conditions on the pace of business expansion. A local decline in this metric amid margin compression signals risks regarding the efficiency of asset management.